289 related articles for article (PubMed ID: 11260540)
1. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.
Ho VC; Griffiths CE; Berth-Jones J; Papp KA; Vanaclocha F; Dauden E; Beard A; Puvanarajan L; Paul C
J Am Acad Dermatol; 2001 Apr; 44(4):643-51. PubMed ID: 11260540
[TBL] [Abstract][Full Text] [Related]
2. Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group.
Ho VC; Griffiths CE; Albrecht G; Vanaclocha F; León-Dorantes G; Atakan N; Reitamo S; Ohannesson A; Mørk NJ; Clarke P; Pfister P; Paul C
Br J Dermatol; 1999 Aug; 141(2):283-91. PubMed ID: 10468801
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety of cyclosporine in the treatment of psoriasis.
Grossman RM; Chevret S; Abi-Rached J; Blanchet F; Dubertret L
Arch Dermatol; 1996 Jun; 132(6):623-9. PubMed ID: 8651712
[TBL] [Abstract][Full Text] [Related]
4. Intermittent vs. continuous 1-year cyclosporin use in chronic plaque psoriasis.
Chaidemenos GC; Mourellou O; Avgoustinaki N; Papakonstantinou M; Karakatsanis G; Katsambas A
J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1203-8. PubMed ID: 17894706
[TBL] [Abstract][Full Text] [Related]
5. The efficacy, tolerability and safety of a new oral formulation of Sandimmun--Sandimmun Neoral in severe refractory atopic dermatitis.
Atakan N; Erdem C
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):240-6. PubMed ID: 9883436
[TBL] [Abstract][Full Text] [Related]
6. A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life.
Czech W; Bräutigam M; Weidinger G; Schöpf E
J Am Acad Dermatol; 2000 Apr; 42(4):653-9. PubMed ID: 10727313
[TBL] [Abstract][Full Text] [Related]
7. Treatment of psoriasis with intermittent short course cyclosporin (Neoral). A multicentre study.
Berth-Jones J; Henderson CA; Munro CS; Rogers S; Chalmers RJ; Boffa MJ; Norris PG; Friedmann PS; Graham-Brown RA; Dowd PM; Marks R; Sumner MJ
Br J Dermatol; 1997 Apr; 136(4):527-30. PubMed ID: 9155952
[TBL] [Abstract][Full Text] [Related]
8. Short-term cyclosporin monotherapy for chronic severe plaque-type psoriasis.
Jan V; Vaillant L; Bressieux JM; Barthélemy H; Legoux A; Steiner HG; Reigneau O
Eur J Dermatol; 1999 Dec; 9(8):615-7. PubMed ID: 10586127
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgaris.
Hashizume H; Ito T; Yagi H; Takigawa M; Kageyama H; Furukawa F; Hata M; Shirahama S; Tanaka M; Higashishiba T; Machida H; Tsushima T; Matsushita K
J Dermatol; 2007 Jul; 34(7):430-4. PubMed ID: 17584318
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of a fixed-dose cyclosporin microemulsion (100 mg) for the treatment of psoriasis.
Shintani Y; Kaneko N; Furuhashi T; Saito C; Morita A
J Dermatol; 2011 Oct; 38(10):966-72. PubMed ID: 21545506
[TBL] [Abstract][Full Text] [Related]
11. Intermittent cyclosporin A treatment of severe plaque psoriasis. Long-term follow-up of 26 patients.
Peluso AM; Bardazzi F; Tosti A; Varotti C
Acta Derm Venereol Suppl (Stockh); 1994; 186():90-1. PubMed ID: 8073851
[TBL] [Abstract][Full Text] [Related]
12. Short-term changes in renal function, blood pressure, and electrolyte levels in patients receiving cyclosporine for dermatologic disorders.
Gupta AK; Rocher LL; Schmaltz SP; Goldfarb MT; Brown MD; Ellis CN; Voorhees JJ
Arch Intern Med; 1991 Feb; 151(2):356-62. PubMed ID: 1992963
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis.
Erkko P; Granlund H; Nuutinen M; Reitamo S
Br J Dermatol; 1997 Jan; 136(1):82-8. PubMed ID: 9039300
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
[TBL] [Abstract][Full Text] [Related]
15. Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy.
Ellis CN; Fradin MS; Hamilton TA; Voorhees JJ
Arch Dermatol; 1995 Jul; 131(7):791-5. PubMed ID: 7611794
[TBL] [Abstract][Full Text] [Related]
16. A comparison of two cyclosporine dosage regimens for the treatment of severe psoriasis.
Yoon HS; Youn JI
J Dermatolog Treat; 2007; 18(5):286-90. PubMed ID: 17852632
[TBL] [Abstract][Full Text] [Related]
17. Optimal time for therapeutic drug monitoring of cyclosporine microemulsion in patients with psoriasis.
Umezawa Y; Ozawa A
Int J Dermatol; 2007 Jul; 46(7):763-6. PubMed ID: 17614813
[TBL] [Abstract][Full Text] [Related]
18. Preprandial vs. postprandial pharmacokinetics of cyclosporine in patients with psoriasis.
Umezawa Y; Mabuchi T; Ozawa A
Int J Dermatol; 2007 Aug; 46(8):880-2. PubMed ID: 17651179
[TBL] [Abstract][Full Text] [Related]
19. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.
Kimball AB; Gold MH; Zib B; Davis MW;
J Am Acad Dermatol; 2008 Sep; 59(3):448-54, 454.e1. PubMed ID: 18539358
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
Aydin F; Canturk T; Senturk N; Turanli AY
Clin Exp Dermatol; 2006 Jul; 31(4):520-4. PubMed ID: 16716153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]